Basilea gets USD 39M BARDA funding for antifungals fosmanogepix
08 Jul 2025 //
GLOBENEWSWIRE
Basilea Starts Phase 3 Study Of Fosmanogepix In Candidiasis
23 Sep 2024 //
GLOBENEWSWIRE
Basilea Partners With BARDA For Novel Antimicrobials
19 Sep 2024 //
GLOBENEWSWIRE